Brief: Hansa Biopharma Appoints Renée Aguiar-Lucander As CEO
24/04/2025 06:06
April 24 (Reuters) - Hansa Biopharma AB HNSA.ST: HANSA BIOPHARMA APPOINTS NEW CHIEF EXECUTIVE OFFICER HANSA BIOPHARMA AB - APPOINTS RENÉE AGUIAR-LUCANDER AS CEO HANSA BIOPHARMA AB - SØREN TULSTRUP STEPS DOWN AS CEO OF HANSA BIOPHARMA Source text: ID:nWkr5gZbKR Further company coverage: HNSA.ST ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hansa Biopharma AB
See all newsBrief: Hansa Biopharma Q3 Rev Up At SEK 143 Mln
Sweden's Hansa Biopharma Q3 revenue surges on SERB license deal
Brief: Hansa Biopharma Q3 Net Income SEK -178.5 Million
Brief: Hansa Biopharma Announces Positive Idefirix Paes Results Presented In The High-Impact Clinical Trials Session At Asn Kidney Week
Brief: Hansa Biopharma Submits IND Application To FDA For HNSA-5487 In GBS